Literature DB >> 17644620

Long-term predictors of insulin resistance: role of lifestyle and metabolic factors in middle-aged men.

Ulf Risérus1, Johan Arnlöv, Lars Berglund.   

Abstract

OBJECTIVE: Predictors of insulin resistance have hitherto only been examined in cross-sectional studies without information on lifestyle factors. Few researchers have measured insulin sensitivity directly and compared different metabolic and lifestyle predictors in a large population. RESEARCH DESIGN AND METHODS: Our aim was to investigate independent long-term predictors of insulin sensitivity in a large population-based sample (the Uppsala Longitudinal Study of Adult Men cohort) of 50-year-old men who underwent a euglycemic clamp 20 years later (n = 770). Subjects with diabetes and treatment of cardiovascular disease at baseline were excluded. In linear regression models, metabolic (BMI, triglycerides, HDL cholesterol, glucose, and blood pressure) and lifestyle factors (physical activity, smoking, saturated fat biomarkers, and socioeconomic status) were independent variables at baseline (age 50 years) and insulin sensitivity-dependent variables at follow-up (age 70 years). A subsample of only normal-weight men from the initial population was also examined (n = 440).
RESULTS: BMI was the strongest predictor of insulin sensitivity even after addition of metabolic factors. One SD (+/-2.8) increase in BMI corresponded to a mean 19% decrease in insulin sensitivity. After addition of lifestyle factors, all factors except triglycerides and smoking were significant predictors. BMI remained the strongest predictor (beta = -0.67 [95% CI -0.83 to -0.51], P < 0.0001) followed by physical activity, HDL cholesterol, saturated fat, and socioeconomic status (all P < 0.05). BMI remained the strongest predictor in normal-weight subjects also (P < 0.001). In addition, after adjustment for baseline insulin concentrations, BMI remained the strongest predictor (P < 0.001).
CONCLUSIONS: Multiple factors, including novel factors such as saturated fat and socioeconomic status, independently predict insulin sensitivity after 20 years. BMI is, however, the single strongest predictor, even in normal-weight subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644620     DOI: 10.2337/dc07-0360

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  33 in total

1.  Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.

Authors:  Laura R Rekedal; Elena Massarotti; Rajesh Garg; Radhika Bhatia; Timothy Gleeson; Bing Lu; Daniel H Solomon
Journal:  Arthritis Rheum       Date:  2010-12

2.  Obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors.

Authors:  Niyati Parekh; Tomoko Okada; Grace L Lu-Yao
Journal:  J Am Diet Assoc       Date:  2009-08

3.  Estimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Lisa S Chow; Shuzhen Li; Lynn E Eberly; Elizabeth R Seaquist; John H Eckfeldt; Ron C Hoogeveen; David J Couper; Lyn M Steffen; James S Pankow
Journal:  Metabolism       Date:  2012-07-21       Impact factor: 8.694

4.  A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders.

Authors:  Lakshmi Subramanian; Abrar A Khan; Prasanna K R Allu; Malapaka Kiranmayi; Bhavani S Sahu; Saurabh Sharma; Madhu Khullar; Ajit S Mullasari; Nitish R Mahapatra
Journal:  J Biol Chem       Date:  2017-06-30       Impact factor: 5.157

5.  The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1.

Authors:  Jay M Sosenko; Susan Geyer; Jay S Skyler; Lisa E Rafkin; Heba M Ismail; Ingrid M Libman; Yuk-Fun Liu; Linda A DiMeglio; Carmella Evans-Molina; Jerry P Palmer
Journal:  Pediatr Diabetes       Date:  2017-11-24       Impact factor: 4.866

6.  Multi-year reproducibility of hyperinsulinemic euglycemic clamp-derived insulin sensitivity in free-living adults: Association with incident prediabetes in the POP-ABC study.

Authors:  Deirdre James; Nkiru Umekwe; Chimaroke Edeoga; Ebenezer Nyenwe; Sam Dagogo-Jack
Journal:  Metabolism       Date:  2020-05-20       Impact factor: 8.694

7.  Repeatability and reproducibility of the hyperinsulinemic-euglycemic clamp and the tracer dilution technique in a controlled inpatient setting.

Authors:  Duc Son N T Le; Thomas Brookshire; Jonathan Krakoff; Joy C Bunt
Journal:  Metabolism       Date:  2009-03       Impact factor: 8.694

8.  Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers.

Authors:  Cari L Meinhold; Amy Berrington de Gonzalez; Demetrius Albanes; Stephanie J Weinstein; Philip R Taylor; Jarmo Virtamo; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2008-12-13       Impact factor: 2.506

9.  Laser beam measurement of abdominal sagittal diameter in obese children: a validation study.

Authors:  C E Flodmark; W Shen; M Punyanitya; P Leander; J Lanke; A Pietrobelli
Journal:  Pediatr Obes       Date:  2012-09-21       Impact factor: 4.000

10.  Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase.

Authors:  Karine H Hellemans; Jean-Claude Hannaert; Bart Denys; Knut R Steffensen; Cindy Raemdonck; Geert A Martens; Paul P Van Veldhoven; Jan-Ake Gustafsson; Daniel Pipeleers
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.